The Control of Seborrhoeic Dermatitis and Dandruff by Antipityrosporal Drugs

Summary

For many years the exact nature of the pathophysiology of seborrhoeic dermatitis and dandruff was in doubt. Different schools of thought debated whether Pityrosporum yeasts were of primary pathogenic significance or a secondary phenomenon, with epidermal hyperproliferation as the primary pathology.

Although effective therapy in seborrhoeic dermatitis and dandruff has for a long time been based on compounds whose only common link was antipityrosporal activity, proof of this relevance was lacking until the introduction of effective antifungal drugs, in particular ketoconazole.

This article charts the swing of opinion towards the primary pityrosporal aetiology of seborrhoeic dermatitis and dandruff, reviews the evidence that antipityrosporal activity is the common link to various compounds which benefit these conditions, and compares the efficacy of these substances in treatment.

This is a preview of subscription content, log in to check access.

References

  1. Alexander S. Loss of hair and dandruff. British Journal of Dermatology 79: 549–552, 1967

    PubMed  Article  CAS  Google Scholar 

  2. Belew PW, Rosenberg EW, Jennings BR. Activation of the alternative pathway of complement by Malassezia ovalis (Pityrosporumovale). Mycopathologia 70: 187–191, 1980

    PubMed  Article  CAS  Google Scholar 

  3. Bergsma W, Roster M. Ketoconazole 2% cream in the treatment of seborrhoeic dermatitis. Proceedings of a satellite symposium to the 2nd International Skin Therapy Symposium, Antwerp, 1988, pp. 49–50, Janssen Pharmaceutica, 1988

  4. Blatchford NR. The pharmacokinetics of ketoconazole 2% cream and shampoo. Proceedings of a satellite symposium to the 2nd International Skin Therapy Symposium, Antwerp, 1988, pp. 46–48, Janssen Pharmaceutica, 1988

  5. Borges M. Ultrastructural correlates of antimycotic treatment. Current Topics in Medical Mycology 2: 1, 1986

    Article  Google Scholar 

  6. Boughton K. Ketoconazole and hepatic reactions. South African Medical Journal 63: 955, 1983

    PubMed  CAS  Google Scholar 

  7. Boyle J, Burton JL, Faergemann J. Use of topical lithium succinate for seborrhoeic dermatitis. British Medical Journal 292: 28, 1986

    PubMed  Article  CAS  Google Scholar 

  8. Burton JL, Cunliffe WJ, Stafford I, Shuster S. The effect of facial nerve paresis on sebum excretion. British Journal of Dermatology 84: 135–138, 1971

    PubMed  Article  CAS  Google Scholar 

  9. Butterfield W. Sensitivities of Pityrosporum sp to selected commercial shampoos. British Journal of Dermatology 116: 233–235, 1987

    PubMed  Article  CAS  Google Scholar 

  10. Carr MM, Pryce DM, Ive FA. Treatment of seborrhoeic dermatitis with ketoconazole. 1. Response of seborrhoeic dermatitis of the scalp to topical ketoconazole. British Journal of Dermatology 116: 213–216, 1987

    PubMed  Article  CAS  Google Scholar 

  11. Cauwenbergh G. International experience with ketoconazole shampoo in the treatment of seborrhoeic dermatitis and dandruff. In Shyster S & Blatchford N (Eds) Seborrhoeic dermatitis and dandruff: a fungal disease, Royal Society of Medicine International Congress and Symposium Series, No. 132, pp. 35–42, Royal Society of Medicine Services Ltd, 1988

  12. Chandler CJ, Segel IH. Mechanism of the antimicrobial action of pyrithione: effects on membrane transport, ATP levels, and protein synthesis. Antimicrobial Agents and Chemotherapy 14: 60–68, 1978

    PubMed  Article  CAS  Google Scholar 

  13. Cowley NC, Farr PM, Shuster S The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neu-rological disorders. British Journal of Dermatology 122: 71–76, 1990

    PubMed  Article  CAS  Google Scholar 

  14. Cunliffe WJ. A double blind placebo-controlled crossover study to determine the incidence and severity of dermal irritaricy of ketoconazole 2% cream. Clinical Research Report, Janssen Pharmaceutica, 1982

  15. De Doncker P, Legendre B, Van Lint J, Woestenborghs R, Hueb-’ ner G, et al. Chronic use of ketoconazole 2% shampoo in patients with seborrhoeic dermatitis and dandruff. 2nd International Skin Therapy Symposium, Antwerp, May 5 1988, pp. 59–60, Janssen Pharmaceutica, 1988

  16. Faergemann J. In vitro and in vivo activities of ketoconazole and itraconazole against Pityrosporum ovale. Antimicrobial Agents and Chemotherapy 26: 773–775, 1984

    PubMed  Article  CAS  Google Scholar 

  17. Faergemann J. Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole md hydro* cortisone. British Journal of Dermatology 114: 695–700, 1986

    PubMed  Article  CAS  Google Scholar 

  18. Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole. Lancet 2: 1271–1272, 1984

    PubMed  Article  CAS  Google Scholar 

  19. Ford GP, Farr PM, Ive FA, Shuster S. The response of seborrhoeic dermatitis to ketoconazole. British Journal of Dermatology 111: 603–607,1984

    PubMed  Article  CAS  Google Scholar 

  20. Fredriksson T. Controlled comparison of Clinitar shampoo and Selsun shampoo in the treatment of seborrhoeic dermatitis of the scalp. British Journal of Clinical Practice 39: 25–28, 1985

    PubMed  CAS  Google Scholar 

  21. Gosse RM, Vanderwyk RW. The relationship of a nystatin-resistant strain of Pityrosporum ovale to dandruff. Journal of the Society of Cosmetic Chemists 20: 603–613, 1969

    Google Scholar 

  22. Green CA, Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole. British Journal of Dermatology 116: 217–221, 98rh

  23. Grossier D, Bottone EJ, Lebwohl M. Association of Pityrosporum orbiculare (Malassezia furfur) with seborrhoeic dermatitis in patients with acquired immunodeficiency syndrome. Journal of the American Academy of Dermatology 20(5): 770–773, 1989

    Article  Google Scholar 

  24. Guin JD. Double-blind comparison of 2% ketoconazole cream in the treatment of seborrhoeic dermatitis. Clinical Research Report R 41 400/139, Janssen Pharmacutica, 1985

  25. Hickman J. A randomized double-blind placebo controlled comparison of ketoconazole 2% shampoo and selenium sulphide 2.5% shampoo in the treatment of moderate to severe dandruff. Clinical Research Report R 41 400, Janssen Pharmaceutica, 1988

  26. Hull PR, Presbury DGC. Ketoconazole in the treatment of seborrhoeic dermatitis: a double blind placebo controlled study. Clinical Research Report R 41 400/165, Janssen Pharmaceutica, 1988

  27. Jacobs PH. Seborrhoeic dermatitis; causes and management. Cutis 41: 182–184, 1988

    Google Scholar 

  28. Kantor I. Medicated anti-dandruff shampoo with 1% ketoconazole: clinical efficacy study vs Head and Shoulders shampoo. Research Report, Johnson and Johnson Baby Products Co, pp. 87–102, 1987

  29. Kligman AM, McGinley KJ, Leyden JJ. The nature of dandruff. Journal of the Society of Cosmetic Chemists 27: 111–139, 1979

    Google Scholar 

  30. Leeming JP, Burton JL. Lithium succinate and seborrhoeic dermatitis: an antifungal mode of action? Correspondence. British Journal of Dermatology 122: 718–719, 1990

    PubMed  Article  CAS  Google Scholar 

  31. Malassez L. Note sur le champignon du pityriasis simple. Archives de Physiologie 2: 451, 1874

    Google Scholar 

  32. Marks R, Pearse AD, Walker AP. The effects of a shampoo containing the zinc pyrithione on the control of dandruff. British Journal of Dermatology 112: 415–422, 1985

    PubMed  Article  CAS  Google Scholar 

  33. Mathes BN, Douglass MC. Seborrhoeic dermatitis in patients with AIDS. Journal of the American Academy of Dermatology 13: 947–951, 1985

    PubMed  Article  CAS  Google Scholar 

  34. McGinley KJ, Leyden JJ, Marples BN, Kligman AM. Quantitative microbiology in non-dandruff and seborrhoeic dermatitis. Journal of Investigative Dermatology 64: 401–404, 1975

    PubMed  Article  CAS  Google Scholar 

  35. McLeod JMH, Dowling GB. An experimental study of the pityrosporum of Malassez: its morphology, cultivation and pathogenicity. British Journal of Dermatology XL: 139–148, 1928

    Article  Google Scholar 

  36. Mertens R, Vankeerberghen R, Van Lint J. Ketoconazole 2% shampoo in the treatment of dandruff and for seborrhoeic dermatitis: a double-blind placebo controlled study. Clinical Research Report R 41 400/162, Janssen Pharmaceutica, 1987

  37. Midgley G, Hay RJ. Detection of antibodies to Pityrosporum in human serum. British Journal of Dermatology 116: 457, 1987

    Google Scholar 

  38. Moore M, Kile RL, Engman JR, Engman MF. Pityrosporum ovale (bottle bacillus of unna, spore of malassez) cultivation and possible role in seborrhoeic dermatitis. Archives of Dermatology of Syphilology 33: 457–472, 1936

    Article  Google Scholar 

  39. Peereboom-Wynia JDR, Koster M. Treatment of seborrhoeic dermatitis of the scalp and dandruff with ketoconazole 2% scalp gel. Proceedings of a satellite symposium to the 2nd International Skin Therapy Symposium, Antwerp, 1988, pp. 51–52, Janssen Pharmaceutica, 1988

  40. Pochi PE, Strauss JS, Mescon H. Sebum production and fractional 17 ketosteroid excretion in Parkinsonism. Journal of Investigative Dermatology 38: 45–51, 1962

    PubMed  CAS  Google Scholar 

  41. Rappaport M. A randomized, controlled clinical trial of four anti-dandruff shampoos. Journal of International Medical Research 9: 152–156, 1981

    Google Scholar 

  42. Rivolta S. Parasitti vegetali, 1st ed., pp. 469–471, Giulio Speirani, Torino, 1873

    Google Scholar 

  43. Rosenberg EW. Double-blind comparison of 2% ketoconazole cream in the treatment of seborrhoeic dermatitis. Clinical Research Report R41 400/138, Janssen Pharmaceutica, 1985

  44. Sabouraud R. Pityriasis et alopecies peliculaires. In Les maladies desquamatives, 1st ed., p. 295, Masson et Cie, Paris, 1904

  45. Schrooten P, Cauwenbergh G. Ketoconazole shampoo in the treatment of dandruff or seborrhoeic dermatitis; a double-blind placebo controlled study. Clinical Research Report R 41 400/ 157, Janssen Pharmaceutica, 1986

  46. Shifrine M, Marr AG. The requirement of fatty acids by Pityrosporum ovale. Journal of General Microbiology 32: 263, 1963

    PubMed  Article  CAS  Google Scholar 

  47. Shuster S. The aetiology of dandruff and the mode of action of therapeutic agents. British Journal of Dermatology 111: 235–242, 1984

    PubMed  Article  CAS  Google Scholar 

  48. Shuster S. Introduction: a history. In Shuster S & Blatchford N (Eds) Seborrhoeic dermatitis and dandruff: a fungal disease, Royal Society of Medicine International Congress and Symposium Series, No. 132, pp. 1–4, Royal Society of Medicine Services Ltd, 1988

  49. Skinner RB, Noah PW, Taylor RM, Zanolli MD, West S, et al. Double-blind treatment with 2% ketoconazole cream. Journal of the American Academy of Dermatology 12: 852–856, 1985

    PubMed  Article  Google Scholar 

  50. Stoppie P, Cauwenbergh G, Van de Heyning-Meier J, De Greef H, Borgers M. An autoradiographic study of the penetration of a 2% ketoconazole formulation into human skin. Advances in Therapy 4: 219, 1987

    Google Scholar 

  51. Stratigos JS, Katsambas A, Antoniou CH, Argerinou G, Michailides D. Ketoconazole 2% cream v hydrocortisone 1% cream in the treatment of seborrhoeic dermatitis; a double-blind comparative study. Proceedings of a satellite symposium to the 2nd International Skin Therapy Symposium, Antwerp, 1988, pp. 54–55, Janssen Pharmaceutica, 1988

  52. Tanew A. A randomized study with ketoconazole shampoo 2% or Selsun R (selenium sulphide 2.5%) in the treatment of seborrhoeic dermatitis and/or dandruff. Clinical Research Report R41 400/172, Janssen Pharmaceutica, 1987

  53. Thody AJ, Shuster S. Control and function of sebaceous glands. Physiological Reviews 69: 283–416, 1989

    Google Scholar 

  54. Thulliez M, Cornelis H, Schiettekatte L, Vankeerberghen R, Of-fermans W, et al. Comparison of 4 concentrations of a ketoconazole shampoo with a placebo shampoo in dandruff and/ or seborrhoeic dermatitis. Clinical Research Report R41 400/ 161, Janssen Pharmaceutica, 1987

  55. Tooley PJH, Naismith D, Nijjar AS, Collins K, Brown A, et al. An open, parallel group comparative study of ketoconazole 2% shampoo and selenium sulphide 2.5% shampoo in the treatment of dandruff. Clinical Research Report, Janssen Pharmaceutica, 1989

  56. Unna PG. Seborrhoeic eczema. Journal of Cutaneous and Genitourinary Disorders 5: 449–453, 1887

    Google Scholar 

  57. Van Cutsem J, Van Gerven F, Van Peer A, Woestenborghs R, Fransen J, et al. Ketoconazole concentration in plasma and hair samples from volunteers after 8 weeks application of a ketoconazole 2% shampoo. Clinical Research Report R41 400/ 152, Janssen Pharmaceutica, 1986

  58. Van Derheyden D, Cauwenbergh G, Thulliez M, Cornelis H, Schiettekatte L, et al. Ketoconazole shampoo in the treatment of dandruff and/or seborrhoeic dermatitis: a randomized double-blind placebo controlled comparison of different concentrations. Clinical Research Report R41 400/163, Janssen Pharmaceutica, 1987

  59. Vanderwyk RW, Hechemy KE. A comparison of the bacterial and yeast flora of the human scalp and their effects upon dandruff production. Journal of the Society of Cosmetic Chemists 18: 629–639, 1967

    Google Scholar 

  60. Weary PE. Pityrosporum ovale: observations on some aspects of host-parasite interrelationships. Archives of Dermatology 98: 408, 1968

    Article  Google Scholar 

  61. Whitmore MC. Double-blind comparison of 2% ketoconazole cream in the treatment of seborrhoeic dermatitis. Clinical Research Report R41 400/136, Janssen Pharmaceutica, 1985

  62. Wilson CL, Walshe M. Incidence of seborrhoeic dermatitis in spinal injury patients. British Journal of Dermatology 119: 485, 1988

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Dr John A. McGrath.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

McGrath, J.A., Murphy, G.M. The Control of Seborrhoeic Dermatitis and Dandruff by Antipityrosporal Drugs. Drugs 41, 178–184 (1991). https://doi.org/10.2165/00003495-199141020-00003

Download citation

Keywords

  • Ketoconazole
  • Seborrhoeic Dermatitis
  • Zinc Pyrithione
  • Cosmetic Chemist
  • Epidermal Hyperproliferation